BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21240077)

  • 1. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hicks SC; Ward RL; Hawkins NJ
    Pathology; 2011 Jan; 43(1):84-5; author reply 85-6. PubMed ID: 21240077
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.
    Shia J; Tang LH; Vakiani E; Guillem JG; Stadler ZK; Soslow RA; Katabi N; Weiser MR; Paty PB; Temple LK; Nash GM; Wong WD; Offit K; Klimstra DS
    Am J Surg Pathol; 2009 Nov; 33(11):1639-45. PubMed ID: 19701074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemistry screening for Lynch syndrome in colorectal adenocarcinoma using an initial two antibody panel can replace a four antibody panel.
    O'Regan T; Chau K; Tatton M; Smith T; Parry S; Bissett I
    N Z Med J; 2013 Sep; 126(1382):70-7. PubMed ID: 24154771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas.
    Mojtahed A; Schrijver I; Ford JM; Longacre TA; Pai RK
    Mod Pathol; 2011 Jul; 24(7):1004-14. PubMed ID: 21499234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
    J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical problem-solving. Spot diagnosis.
    Stark Z; Campbell LJ; Mitchell C; James PA; Heath JA; Boussioutas A; Lynch C; Trainer AH
    N Engl J Med; 2014 Jun; 370(23):2229-36. PubMed ID: 24897087
    [No Abstract]   [Full Text] [Related]  

  • 8. Interobserver variability in the evaluation of mismatch repair protein immunostaining.
    Klarskov L; Ladelund S; Holck S; Roenlund K; Lindebjerg J; Elebro J; Halvarsson B; von Salomé J; Bernstein I; Nilbert M
    Hum Pathol; 2010 Oct; 41(10):1387-96. PubMed ID: 20573374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PMS2 involvement in patients suspected of Lynch syndrome.
    Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
    Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline mutation and protein expression analysis of mismatch repair genes MSH6 and PMS2 in Malaysian Lynch syndrome patients.
    Zahary MN; Kaur G; Hassan MR; Sidek AS; Singh H; Yeh LY; Ankathil R
    Int J Colorectal Dis; 2014 Feb; 29(2):261-2. PubMed ID: 24072394
    [No Abstract]   [Full Text] [Related]  

  • 12. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
    Leong V; Lorenowicz J; Kozij N; Guarné A
    Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.
    Xicola RM; Llor X; Pons E; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Duque JM; Nicolás-Pérez D; Garcia AM; Rigau J; Gassull MA;
    J Natl Cancer Inst; 2007 Feb; 99(3):244-52. PubMed ID: 17284719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
    Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
    Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response.
    Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH
    Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PMS2 mutations in HNPCC.
    Hayward BE; De Vos M; Sheridan E; Bonthron DT
    Clin Genet; 2004 Dec; 66(6):566-7; author reply 568. PubMed ID: 15521988
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.
    Drost M; Koppejan H; de Wind N
    Hum Mutat; 2013 Nov; 34(11):1477-80. PubMed ID: 24027009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Café-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2.
    Jackson CC; Holter S; Pollett A; Clendenning M; Chou S; Senter L; Ramphal R; Gallinger S; Boycott K
    Pediatr Blood Cancer; 2008 Jun; 50(6):1268-70. PubMed ID: 18273873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PMS2-specific colorectal surveillance guideline.
    ten Broeke SW; Nielsen M
    Genet Med; 2015 Aug; 17(8):684. PubMed ID: 26240978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.